Shalby Limited Cash Flow Conversion Efficiency
Shalby Limited cash flow conversion efficiency. Based on the latest financial reports, Shalby Limited (SHALBY) has a cash flow conversion efficiency ratio of 0.014x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs138.47 Million ≈ $1.50 Million USD) by net assets (Rs10.03 Billion ≈ $108.45 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Shalby Limited (2012–2026)
Cash flow conversion efficiency of Shalby Limited from 2012 to 2026. This chart illustrates how Shalby Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View SHALBY stock price and chart for real-time trading data and today's change.
Shalby Limited Cash Flow Conversion Ratio Explained
Shalby Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Shalby Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shalby Limited ranked by their cash flow conversion efficiency. Also see SHALBY market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bera Holding AS
IS:BERA
|
0.013x |
|
Wintermar Offshore Marine Tbk
JK:WINS
|
0.069x |
|
Purple Capital Ltd
JSE:PPE
|
0.014x |
|
Hamat Group Ltd
TA:HAMAT
|
0.059x |
|
Shieh Yih Machinery Industry Co Ltd
TWO:4533
|
0.133x |
|
LBS Bina Group Bhd
KLSE:5789
|
0.025x |
|
Bank Agris Tbk
JK:AGRS
|
0.027x |
|
India Pesticides Limited
NSE:IPL
|
0.084x |
Annual Cash Flow Conversion Efficiency for Shalby Limited (2012–2026)
The table below shows the annual cash flow conversion efficiency of Shalby Limited from 2012 to 2026. Review Shalby Limited free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs10.06 Billion ≈ $108.76 Million |
Rs-333.59 Million ≈ $-3.61 Million |
-0.033x | -5.48% |
| 2025-03-31 | Rs9.95 Billion ≈ $107.64 Million |
Rs-313.01 Million ≈ $-3.39 Million |
-0.031x | -261.73% |
| 2024-03-31 | Rs10.08 Billion ≈ $108.99 Million |
Rs195.96 Million ≈ $2.12 Million |
0.019x | -73.39% |
| 2023-03-31 | Rs9.28 Billion ≈ $100.32 Million |
Rs677.73 Million ≈ $7.33 Million |
0.073x | +238.40% |
| 2022-03-31 | Rs8.76 Billion ≈ $94.76 Million |
Rs189.17 Million ≈ $2.05 Million |
0.022x | -78.64% |
| 2021-03-31 | Rs8.35 Billion ≈ $90.27 Million |
Rs843.49 Million ≈ $9.12 Million |
0.101x | +45.86% |
| 2020-03-31 | Rs7.99 Billion ≈ $86.43 Million |
Rs553.74 Million ≈ $5.99 Million |
0.069x | +57.31% |
| 2019-03-31 | Rs7.80 Billion ≈ $84.34 Million |
Rs343.47 Million ≈ $3.71 Million |
0.044x | +140.70% |
| 2018-03-31 | Rs7.62 Billion ≈ $82.35 Million |
Rs139.34 Million ≈ $1.51 Million |
0.018x | -92.71% |
| 2017-03-31 | Rs2.75 Billion ≈ $29.79 Million |
Rs691.74 Million ≈ $7.48 Million |
0.251x | +1118.55% |
| 2016-03-31 | Rs2.22 Billion ≈ $23.97 Million |
Rs45.68 Million ≈ $494.01K |
0.021x | -97.14% |
| 2015-03-31 | Rs1.71 Billion ≈ $18.47 Million |
Rs1.23 Billion ≈ $13.33 Million |
0.722x | +1936.93% |
| 2014-03-31 | Rs1.43 Billion ≈ $15.51 Million |
Rs50.81 Million ≈ $549.49K |
0.035x | -96.07% |
| 2013-03-31 | Rs1.06 Billion ≈ $11.43 Million |
Rs953.70 Million ≈ $10.31 Million |
0.902x | +2100.17% |
| 2012-03-31 | Rs892.99 Million ≈ $9.66 Million |
Rs-40.27 Million ≈ $-435.50K |
-0.045x | -- |
About Shalby Limited
Shalby Limited operates a chain of multi-specialty hospitals in India and internationally. The company operates through Healthcare Services and Manufacturing segments. It offers rheumatology, knee and hip joint replacement, spine surgery, Paediatric orthopedic and trauma, arthroscopy, and arthroplasty; cardiothoracic and vascular surgery, coronary angiography, angioplasty and stenting, and cardio… Read more